Shortlists Named for 2026 VISION Award
Organizers of VISION 2026, set to take place Oct. 6-8 in Stuttgart, have unveiled their shortlist for the VISION Award. The five companies will present their innovations during a 1-h session at the Industrial Vision Days on Oct. 7.
Sifted acquires Onstage to strengthen its European startup community and events offering
European tech media company Sifted has acquired startup events platform Onstage, expanding its founder-focused offering with one of Europe’s leading Demo Day communities. The acquisition marks Sifted’s first-ever acquisition and aims to help the company support founders from the earliest stages of fundraising through to scaleup growth.
Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials
Series B funding will accelerate development of new AI disease models for lung and heart conditions, while expanding the company's imaging analytics platform.
Robot fruit-picking firm harvests growth with £14 million raise
A robotics business is set to accelerate the rollout of artificial intelligence-powered harvesting technology after securing more than £14 million support.
Dogtooth Technologies has raised funding through equity investment from 24 Haymarket, EMV Capital and ACF Investors, alongside grants from Innovate UK and a venture leasing facility from Kineo Finance.
Industry heavyweights join new advisory team at Paragraf
Cambridgeshire technology innovator Paragraf has added to its world-leading credentials by adding three international heavyweights to a new Advisory Committee. Two of them will also reinforce the Board.
Exonate appoints Olav Hellebø as Chief Executive Officer
Exonate appoints Olav Hellebø as Chief Executive Officer
Heartfelt receives Breakthrough Device Designation from FDA for heart failure monitoring tech
A groundbreaking AI-powered device developed by Heartfelt Technologies in Cambridge could be set to revolutionise how heart failure is managed in the home, after receiving Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
Undo raises £27.6m to boost software issue diagnosis by AI agents
The funding will be used to expand go-to-market teams across the US and Europe
How ‘RNA origami’ could improve neurodegenerative disease diagnosis
University of Cambridge researchers have discovered what appears to be a transformative method of identifying mutations linked to genetic disorders.
PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry
Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1.
Cambridge startup Signaloid tapes out C0-ASIC, delivering 1000x energy savings for AI
Signaloid, a Cambridge computing platform company providing hardware and binary-translation-based acceleration of AI, robotics, aerospace, and quantitative finance workloads, has launched the tapeout and preliminary specifications documents for its C0-ASIC processor.
Renaissance and CyberSmart Partner to Deliver Complete Cyber Confidence for SMEs
Renaissance has announced a strategic partnership with CyberSmart, a UK-based cybersecurity provider focused on delivering continuous protection, compliance, and cyber risk management for small and medium-sized enterprises (SMEs).
Signaloid announces preview of new ASIC targeted at physical AI and robotics applications
Signaloid previews a new ASIC purpose-built for physical AI and robotics workloads.
Verinnogen raises £500k to advance cancer drug development
CPI Enterprises, part of the High Value Manufacturing Catapult, has invested £500,000 in Cambridge-based life sciences company Verinnogen to support the development of a novel technology designed to improve the accuracy and reliability of cancer drug development.
Rethinking Clinical Trials with Synthetic Control Arms
Kiril Kirov from Qureight discusses how synthetic control arms offer an alternative to conventional control groups and improve clinical trial design.
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies.
10 UK startups revolutionising patient care through digital health
The NHS is one of the world’s most ambitious public health systems, but it faces mounting pressures from an ageing population, chronic illnesses, and limited public funding.
Dorset bird song recordings offer new insight into diversity
Cutting-edge sound technology has laid bare a stark contrast in bird life between conventional and regenerative farming in just six days.
Healx AI: 10 Essential Facts About the Cambridge Rare Disease Drug Discovery Pioneer
Healx, a leading UK artificial intelligence-powered biotech company, continues to reshape drug discovery for rare diseases in 2026, leveraging advanced machine learning to accelerate treatments for conditions that affect millions but often lack approved therapies.
Patients Know Best and Heartfelt Technologies collaborate to accelerate clinical trial recruitment
Patients Know Best has collaborated with Heartfelt Technologies to automate and accelerate clinical trial recruitment, by taking a digital-first approach to patients.